Literature DB >> 19445777

Blood sampling in infants (reducing pain and morbidity).

Olga Kapellou1.   

Abstract

INTRODUCTION: Preterm or ill neonates may undergo 1-21 heel punctures or venepunctures per day. These punctures are likely to be painful. Heel punctures comprise 61-87% and venepunctures comprise 8-13% of the invasive procedures performed on ill infants. Analgesics are rarely given specifically for blood sampling procedures, but 5-19% of infants receive analgesia for other indications. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of interventions to reduce pain-related distress and morbidity during venepuncture in preterm or term babies aged under 12 months in a neonatal unit? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 16 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: oral sweet solutions, pacifiers, and topical anaesthetics (lidocaine-prilocaine cream, tetracaine).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19445777      PMCID: PMC2907791     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  20 in total

1.  Randomised trial of analgesic effects of sucrose, glucose, and pacifiers in term neonates.

Authors:  R Carbajal; X Chauvet; S Couderc; M Olivier-Martin
Journal:  BMJ       Date:  1999-11-27

2.  Assessment of the effect of EMLA during venipuncture in the newborn by analysis of heart rate variability.

Authors:  Viveca Lindh; Urban Wiklund; Stellan Håkansson
Journal:  Pain       Date:  2000-06       Impact factor: 6.961

3.  No more tears: a randomized controlled double-blind trial of Amethocaine gel vs. placebo in the management of procedural pain in neonates.

Authors:  J Moore
Journal:  J Adv Nurs       Date:  2001-05       Impact factor: 3.187

Review 4.  Does oral sucrose reduce the pain of neonatal procedures?

Authors:  Nicole Horwitz
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

5.  Oral sucrose compares favourably with lidocaine-prilocaine cream for pain relief during venepuncture in neonates.

Authors:  F Abad; N M Díaz-Gómez; E Domenech; D González; M Robayna; M Feria
Journal:  Acta Paediatr       Date:  2001-02       Impact factor: 2.299

Review 6.  Lidocaine-prilocaine cream versus tetracaine gel for procedural pain in children.

Authors:  Anna Taddio; Mona G Y Gurguis; Gideon Koren
Journal:  Ann Pharmacother       Date:  2002-04       Impact factor: 3.154

7.  Does topical amethocaine gel reduce the pain of venepuncture in newborn infants? A randomised double blind controlled trial.

Authors:  A Jain; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

8.  Pain reduction at venipuncture in newborns: oral glucose compared with local anesthetic cream.

Authors:  Maria Gradin; Mats Eriksson; Gunilla Holmqvist; Asa Holstein; Jens Schollin
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

9.  Analgesic effect of oral glucose in preterm infants during venipuncture--a double-blind, randomized, controlled trial.

Authors:  Laxmikant S Deshmukh; Rekha H Udani
Journal:  J Trop Pediatr       Date:  2002-06       Impact factor: 1.165

10.  Randomized trial of novel tetracaine patch to provide local anaesthesia in neonates undergoing venepuncture.

Authors:  C P Long; D F McCafferty; N M Sittlington; H L Halliday; A D Woolfson; D S Jones
Journal:  Br J Anaesth       Date:  2003-10       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.